NCT06463340 - Study of SGR-3515 In Participants With Advanced Solid Tumors. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 18, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

SGR-3515

SGR-3515 will be administered orally with an intermittent schedule.

Trial Locations (14)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

22031

RECRUITING

NEXT Virginia, Fairfax

28204

RECRUITING

Levine Cancer Institute, Charlotte

37203

RECRUITING

Sarah Cannon Research Institute, Nashville

37232

RECRUITING

Vanderbilt-Ingram Cancer Center/Henry-Joyce Cancer Clinic, Nashville

43210

RECRUITING

Ohio State University, Columbus

45267

RECRUITING

University of Cincinnati Medical Center, Cincinnati

48109

RECRUITING

University of Michigan, Ann Arbor

48201

RECRUITING

Karmanos Cancer Institute, Detroit

60611

RECRUITING

Northwestern University, Chicago

73104

RECRUITING

Stephenson Cancer Center, Oklahoma City

75235

RECRUITING

University of Texas Southwestern, Dallas

06520

RECRUITING

Yale University, Yale Cancer Center, New Haven

MSG 1X6

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

lead

Schrödinger, Inc.

INDUSTRY